These Analysts Revise Their Forecasts On Hamilton Lane After Q4 Results
Hamilton Lane Inc (NASDAQ:HLNE) reported mixed results for the fourth quarter on Thursday.
HLNE - Hamilton Lane Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$144.00
DETAILS
HIGH:
$179.00
LOW:
$102.00
MEDIAN:
$148.00
CONSENSUS:
$144.00
UPSIDE:
59.43%
Stock News
Hamilton Lane Inc (HLNE) Stock Up 4.1% and Still Undervalued -- GF Score: 80/100
On May 21, 2026, Hamilton Lane Inc (HLNE) shares rose 4.1% to a current price of $88.49. The stock has experienced significant volatility over the past year, tr
Hamilton Lane Incorporated (HLNE) Q4 2026 Earnings Call Transcript
Hamilton Lane Incorporated (HLNE) Q4 2026 Earnings Call Transcript
Hamilton Lane Q4 Earnings Call Highlights
Hamilton Lane NASDAQ: HLNE reported higher fiscal 2026 revenue and earnings growth, while management used the company's fiscal fourth-quarter earnings call to push back against concerns about private markets and highlight momentum in its evergreen fund platform.
Here's What Key Metrics Tell Us About Hamilton Lane (HLNE) Q4 Earnings
While the top- and bottom-line numbers for Hamilton Lane (HLNE) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Hamilton Lane (HLNE) Beats Q4 Earnings Estimates
Hamilton Lane (HLNE) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.21 per share a year ago.
HAMILTON LANE INCORPORATED REPORTS FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS
CONSHOHOCKEN, Pa., May 21, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) today reported its results for the fourth quarter and full fiscal year ended March 31, 2026.
Hamilton Lane Inc (HLNE) Shares Fall 3.0% -- What GF Score of 80 Tells Investors
On May 19, 2026, Hamilton Lane Inc (HLNE) shares fell 3.0%, closing at $84.11. The stock has been under pressure, trading within a 52-week range of $84.05 to $1
Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #cosettepharma--Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer (Brands). David joins the company's executive leadership team as it continues to advance its ambitions in specialty pharmaceuticals and expand its commercial platform and portfolio. In this new role, David will oversee all branded commercial functions – including sales, marketing, market access, commerc.
Gear Up for Hamilton Lane (HLNE) Q4 Earnings: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Hamilton Lane (HLNE) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Implied Volatility Surging for Hamilton Lane Stock Options
Investors need to pay close attention to HLNE stock based on the movements in the options market lately.
Hamilton Lane (HLNE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Hamilton Lane (HLNE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Power Sustainable Completes Sale of Minority Stake in Big Sky Wind to Institutional Partners
MONTREAL, April 29, 2026 /PRNewswire/ - Power Sustainable Energy Infrastructure ("PSEI"), the renewable energy infrastructure platform of Power Sustainable, today announced it completed the sale of a 49.9% interest in Big Sky Wind, a 240 MW operating wind facility located in Illinois, to funds managed by Hamilton Lane (Nasdaq: HLNE) and GCM Grosvenor, two leading global private markets investment firms. PSEI will retain a majority interest in the asset and continue to oversee its operations.
Hamilton Lane Incorporated Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, April 28, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Hamilton Lane Incorporated (NASDAQ: HLNE). The investigation focuses on Hamilton Lane's executive officers and whether investor losses may be recovered under federal securities laws.
Will Hamilton Lane (HLNE) Beat Estimates Again in Its Next Earnings Report?
Hamilton Lane (HLNE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Hamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2026 Results on May 21, 2026
CONSHOHOCKEN, Pa., April 23, 2026 /PRNewswire/ -- Hamilton Lane Incorporated (Nasdaq: HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2026 before the market opens on Thursday, May 21, 2026.
Hamilton Lane Launches Two Interval Funds Across Private Credit and Private Infrastructure, Leveraging Extensive Expertise and Deep Track Records
The Hamilton Lane Credit Income Fund is now available to institutional and private wealth investors via the interval fund structure The firm's Private Infrastructure Fund is now offered in an interval fund structure and is also available in a tokenized format through Republic's digital platform CONSHOHOCKEN, Pa., April 22, 2026 /PRNewswire/ -- Hamilton Lane (Nasdaq: HLNE) today announced the launch of the Hamilton Lane Credit Income Fund ("HLCIF") and the conversion of the Hamilton Lane Private Infrastructure Fund ("HLPIF") to an interval fund structure.
Hamilton Lane Announces Senior Promotions and Appointments
Over 25 promotions and appointments to Managing Director and Principal reflect the firm's continued growth and expansion of its product offerings and client and investment teams CONSHOHOCKEN, Pa., April 20, 2026 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (Nasdaq: HLNE) today announced senior promotions and new appointments across its Investment, Client Solutions, Portfolio Management, Legal, Finance and Operations Teams.
Strength Seen in Hamilton Lane (HLNE): Can Its 7.4% Jump Turn into More Strength?
Hamilton Lane (HLNE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Hamilton Lane Inc (HLNE) Stock Up 7.4% and Still Undervalued -- GF Score: 86/100
On April 13, 2026, Hamilton Lane Inc (HLNE) shares rose 7.4% to a current price of $99.07. The stock has experienced a broad range over the past year, with a 52
Price Targets
Hamilton Lane price target lowered to $102 from $108 at BMO Capital
$102.00
(was $90.33)
Brennan Hawken
·
BMO Capital
Hamilton Lane price target raised to $179 from $171 at Oppenheimer
$179.00
(was $89.81)
Chris Kotowski
·
Oppenheimer
Hamilton Lane price target raised to $148 from $143 at Goldman Sachs
$148.00
(was $88.59)
Goldman Sachs
Hamilton Lane price target lowered to $141 from $159 at Morgan Stanley
$141.00
(was $109.88)
Michael Cyprys
·
Morgan Stanley
Hamilton Lane price target lowered to $150 from $184 at UBS
$150.00
(was $106.96)
UBS
Hamilton Lane price target raised to $230 from $220 at Oppenheimer
$230.00
(was $140.51)
Oppenheimer
Hamilton Lane price target raised to $159 from $154 at Morgan Stanley
$159.00
(was $148.17)
Morgan Stanley
Hamilton Lane price target raised to $220 from $190 at Oppenheimer
$220.00
(was $151.87)
Oppenheimer
Hamilton Lane price target raised to $184 from $166 at UBS
$184.00
(was $148.30)
Michael Brown
·
UBS
UBS Assumes Hamilton Lane Inc. (HLNE) at Buy
$166.00
(was $132.03)
Michael Brown
·
UBS
Hamilton Lane upgraded to Buy from Neutral at Goldman Sachs
$165.00
(was $123.98)
Goldman Sachs
Hamilton Lane price target lowered to $154 from $169 at Morgan Stanley
$154.00
(was $121.80)
Morgan Stanley
Hamilton Lane upgraded to Outperform from Perform at Oppenheimer
$181.00
(was $122.84)
Chris Kotowski
·
Oppenheimer
Hamilton Lane upgraded to Neutral from Sell at Goldman Sachs
$162.00
(was $146.13)
Goldman Sachs
Hamilton Lane price target lowered to $157 from $190 at Morgan Stanley
$157.00
(was $140.87)
Michael Cyprys
·
Morgan Stanley
Hamilton Lane price target raised to $147 from $139 at Goldman Sachs
$147.00
(was $169.57)
Alexander Blostein
·
Goldman Sachs
Morgan Stanley Maintains Equal-Weight on Hamilton Lane, Lowers Price Target to $101
$101.00
(was $75.08)
Morgan Stanley
Wells Fargo Maintains Equal-Weight on Hamilton Lane, Lowers Price Target to $78
$78.00
(was $73.62)
Wells Fargo